"
Efficacy and Safety of Axitinib as First-Line Therapy in Japanese Patients with Metastatic Renal Cell Carcinoma"
written by Takeshi Namekawa, Satoshi Fukasawa, Atsushi Komaru, Masayuki Kobayashi, Takayuki Ohzeki, Yosuke Sato, Junryo Rii, Hirotsugu Uemura, Tomohiko Ichikawa, Takeshi Ueda,
published by
Journal of Cancer Therapy,
Vol.6 No.8, 2015
has been cited by the following article(s):
|
[1]
|
The efficacy of axitinib as a first‐line treatment for metastatic renal cell carcinoma
Asia-Pacific Journal of Clinical Oncology,
2020
DOI:10.1111/ajco.13323
|
|
|
|
|
[2]
|
The efficacy of axitinib as a first‐line treatment for metastatic renal cell carcinoma
Asia-Pacific Journal of Clinical Oncology,
2020
DOI:10.1111/ajco.13323
|
|
|
|